Despite already posting year-to-date gains of some 260%, compared to flattish returns for the S&P 500 index, one prominent Wall Street analyst recently outlined a scenario where Tesla (TSLA) stock can reach $2,000, thereby producing additional premium of 33%.

Investors will also want to keep tabs on a unified coronavirus budget plan that is winding its way through Washington.

Relative Strength Investing Trends: Market Insights with John Lewis, CMT

But in the background are potential tensions coming from China as it promises to retaliate against the UK’s moves towards Huawei and Hong Kong; plus, Trump noted there might not be a Phase 2 to U.S.-China talks.

Biogen (BIIB) is set to report second quarter fiscal 2020 earnings results before the opening bell Wednesday.

Shares of Nasdaq (NDAQ) have flown under the radar so far in 2020, despite the fact that the company — which is home to some of the biggest names in tech — is trading at all-time highs, delivering some 20% year-to-date gains.

Either the market has to correct, or the news stories have to catch up to the optimism. Here are three stories that will play out this week and that investors should watch closely to see which of those things is more likely.

The active vs. passive debate may depend on the market — all markets are not the same and so we should examine the merits of each style on a market-by-market basis instead of taking a one-size-fits-all approach.

This month, it has been revealed that major cryptocurrency exchange Coinbase has struck deals with multiple organizations within the U.S. federal government as the company prepares to list its stock publicly.

Dr. Anthony Fauci, director of the National Institute for Allergy and Infectious Disease, told Facebook’s (FB) Mark Zuckerberg that he expects results for a clinical trial on monoclonal antibodies by late summer or early fall.